Testing is crucial to combat the pandemic. But with all the funds and attention going towards vaccines, diagnostics is suffering, impeding key steps to curb the spread of the virus

Mark Heywood from the Treatment Action Campaign talks to Kajal Bharadwaj on how Big Pharma’s regressive role remains unchanged, the dangers of the rejection of science and the questions posed by public health crises such as COVID-19

With rich countries and big pharma companies getting proactive, there is widespread apprehension about access and price of the vaccine for countries that need it most.

Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far

In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support

What prevents any country from making drugs and vaccines, once developed? Is it the threat of the US, or the belief that in the US-China vaccine war, they need to be on the US side?